Skip to main content

Lyra Therapeutics, Inc.

LYRADelisted Apr 20, 2026
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001327273

Lyra Therapeutics, Inc. was delisted on Apr 20, 2026; its insiders filed their last Form 4 on May 15, 2026; 23 institutions reported holding it in 13F filings for Q4 2025, worth $747.3K in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Lyra Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
31
−5 vs. Q4 2022
Shares held
18.9M
−148.4K (−0.8%) vs. Q4 2022
Total value
$38.1M
−$21.8M (−36.4%) vs. Q4 2022
New holders
2
5 more added
Sold out
7
4 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 31 institutions
Q1 2021: 50 institutionsQ2 2021: 46 institutionsQ3 2021: 37 institutionsQ4 2021: 34 institutionsQ1 2022: 28 institutionsQ2 2022: 38 institutionsQ3 2022: 38 institutionsQ4 2022: 37 institutionsQ1 2023: 31 institutionsQ2 2023: 39 institutionsQ3 2023: 45 institutionsQ4 2023: 60 institutionsQ1 2024: 79 institutionsQ2 2024: 51 institutionsQ3 2024: 62 institutionsQ4 2024: 54 institutionsQ1 2025: 57 institutionsQ2 2025: 30 institutionsQ3 2025: 26 institutionsQ4 2025: 23 institutionsQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ1 2023: $38.1M
Q1 2021: $87.6MQ2 2021: $56.0MQ3 2021: $60.8MQ4 2021: $22.4MQ1 2022: $20.2MQ2 2022: $108.9MQ3 2022: $96.0MQ4 2022: $59.9MQ1 2023: $38.1MQ2 2023: $138.4MQ3 2023: $124.8MQ4 2023: $222.0MQ1 2024: $283.4MQ2 2024: $9.06MQ3 2024: $8.36MQ4 2024: $5.54MQ1 2025: $3.23MQ2 2025: $4.42MQ3 2025: $2.93MQ4 2025: $747.3KQ1 2026: $51.1KQ2 2026: $0
Institutions holding LYRA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$51.1K
Q4 202523$747.3K
Q3 202526$2.93M
Q2 202530$4.42M
Q1 202557$3.23M
Q4 202454$5.54M
Q3 202462$8.36M
Q2 202451$9.06M
Q1 202479$283.4M
Q4 202360$222.0M
Q3 202345$124.8M
Q2 202339$138.4M
Q1 202331$38.1M
Q4 202237$59.9M
Q3 202238$96.0M
Q2 202238$108.9M
Q1 202228$20.2M
Q4 202134$22.4M
Q3 202137$60.8M
Q2 202146$56.0M
Q1 202150$87.6M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Lyra Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding LYRA in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Perceptive Advisors LLC9,146,730$18.4M0.54%00.0%Unchanged
Nantahala Capital Management, LLC2,220,830$4.46M0.43%00.0%Unchanged
Pura Vida Investments, LLC1,996,972$4.01M0.41%−160,326−7.4%Reduced
Samsara BioCapital, LLC1,777,251$3.57M0.74%00.0%Unchanged
VR Adviser, LLC924,170$1.86M0.36%00.0%Unchanged
Vanguard Group Inc790,936$1.59M0.00%00.0%Unchanged
Soleus Capital Management, L.P.592,417$1.19M0.15%00.0%Unchanged
Ikarian Capital, LLC343,685$711.4K0.30%00.0%Unchanged
Ensign Peak Advisors, Inc302,235$625.6K0.00%00.0%Unchanged
Geode Capital Management, LLC148,840$308.1K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC146,800$303.9K0.01%00.0%Unchanged
Clearline Capital LP119,128$239.4K0.04%00.0%Unchanged
Bank of America Corp104,768$210.6K0.00%+3,014+3.0%Added
Millennium Management LLC58,092$120.0K0.00%+58,092New
Renaissance Technologies LLC47,851$96.0K0.00%+10,651+28.6%Added
BlackRock Inc.41,380$83.2K0.00%+1,266+3.2%Added
State Street Corp37,580$77.8K0.00%00.0%Unchanged
Boothbay Fund Management, LLC34,721$69.8K0.00%00.0%Unchanged
Northern Trust Corp29,829$60.0K0.00%00.0%Unchanged
Two Sigma Advisers, LP28,300$56.9K0.00%−300−1.0%Reduced
Squarepoint Ops LLC11,280$23.4K0.00%+11,280New
Tower Research Capital LLC (TRC)9,972$20.0K0.00%+5,186+108.4%Added
Citadel Advisors LLC7,934$16.4K0.00%−17,343−68.6%Reduced
UBS Group AG853$1.71K0.00%−2,544−74.9%Reduced
Ameliora Wealth Management Ltd.750$1.55K0.00%00.0%Unchanged
Worth Asset Management, LLC650$1.31K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.500$1.00K0.00%00.0%Unchanged
US Bancorp500$1.00K0.00%00.0%Unchanged
Signaturefd, LLC500$1.00K0.00%00.0%Unchanged
Wells Fargo & Company114$2290.00%+1+0.9%Added
JPMorgan Chase & Co34$00.00%00.0%Unchanged
Anson Funds Management LP0$00.00%−39,127−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−13,582−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−3,703−100.0%Sold out
Royal Bank of Canada0$00.00%−491−100.0%Sold out
FMR LLC0$00.00%−450−100.0%Sold out
Investors Research Corp0$00.00%−15−100.0%Sold out
Morgan Stanley0$00.00%−1−100.0%Sold out
CoreCap Advisors, LLC––––Not filed